MDCO Medicines Company

The Medicines Company (NASDAQ:MDCO) will host a conference call on Wednesday, August 9, 2017, at 8:30 a.m., Eastern Daylight Time, to discuss its second-quarter 2017 financial results and operational developments.

A live audio webcast of the conference call may be accessed in the Investors section of The Medicines Company website. A replay of the webcast will be available on the website following the conference call.

The conference call may also be accessed by telephone as follows:

U.S./Canada:     (877) 359-9508 International: (224) 357-2393 Conference ID: 58233884  

A taped replay of the conference call will be available following the call and may be accessed as follows:

U.S./Canada:     (855) 859-2056 International: (404) 537-3406 Conference ID: 58233884  

About The Medicines Company

The Medicines Company is a biopharmaceutical company driven by an overriding purpose — to save lives, alleviate suffering and contribute to the economics of healthcare. The Company’s mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in three critical therapeutic areas: serious infectious disease care, cardiovascular care and surgery and perioperative care. The Company is headquartered in Parsippany, New Jersey, with global innovation centers in California and Switzerland.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170731005210/en/

The Medicines CompanyMediaMeg Langan, 973-290-6319Vice Presidentmargaret.langan@themedco.comorInvestor RelationsKrishna Gorti, M.D., 973-290-6122Vice President, Investor Relationskrishna.gorti@themedco.com